Skip to content

Bio-Techne

US · TECH #1365 by market cap Listed 1970
72.67 -0.03 -0.04%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Rating change
    A Quick Look at Today's Ratings for ODDITY Tech(ODD.US), With a Forecast Between $10 to $21
    Market Newswire · 2026/11/13
  • Company notice
    NASN TECH: (1) CHANGE OF JOINT COMPANY SECRETARY,AUTHORISED REPRESENTATIVE AND PROCESS AGENT;(2) WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND8.17 OF THE LISTING RULES;AND(3) CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
    HKEX · 2026/11/13
  • Analysts: U.S. tech stocks under pressure, European equities relatively resilient
    Latest · 2026/11/14
  • Following Jensen Huang's departure, "The Big Short" investor doubles down on shorting tech stocks, warning that the AI boom may be a "bull trap."
    wallstreetcn · 2026/11/14
  • Datadog vs. DocuSign: Which Tech Stock Is a Better Buy Heading Into 2027?
    HK MoneyClub · 2026/11/13
  • Company notice
    Hangzhou High-Tech: Report on the Issuance of Shares to Specific Investors and Listing on the ChiNext Board by Hangzhou High-Tech Materials Technology Co., Ltd.
    SZSI · 2026/11/13
  • Rating change
    Goldman Sachs Maintains ODDITY Tech(ODD.US) With Sell Rating, Raises Target Price to $10
    Market Newswire · 2026/11/12
  • Rating change
    Barclays Maintains ODDITY Tech(ODD.US) With Sell Rating, Raises Target Price to $15
    Market Newswire · 2026/11/11
  • Rating change
    Craig-Hallum Maintains Health in Tech(HIT.US) With Buy Rating, Cuts Target Price to $2
    Market Newswire · 2026/11/13
  • Rating change
    RBC Capital Maintains Bio-Techne(TECH.US) With Hold Rating, Maintains Target Price $73
    Market Newswire · 2026/11/10
  • Company notice
    Hangzhou High-Tech: Legal Opinion of Zhejiang TianCe Law Firm on the Compliance of the Issuance Process and Subscribers for the 2026 Offering of A-Shares to Specific Investors by Hangzhou High-Tech Materials Technology Co., Ltd.
    SZSI · 2026/11/13
  • Maxim Group Maintains Health in Tech(HIT.US) With Buy Rating, Cuts Target Price to $1
    Market Newswire · 2026/11/13
  • Rating change
    J.P. Morgan Initiates ODDITY Tech(ODD.US) With Hold Rating, Announces Target Price $20
    Market Newswire · 2026/11/14
  • Rating change
    KeyBanc Maintains Tetra Tech Inc(TTEK.US) With Buy Rating, Raises Target Price to $42
    Market Newswire · 2026/11/13
  • Rating change
    Goldman Sachs Maintains CHINA RES BUILDING MATLS TECH HLDGS(CJRCF.US) With Sell Rating, Cuts Target Price to $0.09
    Market Newswire · 2026/11/10
  • Company notice
    Hangzhou High-Tech: Report by Zhongde Securities Co., Ltd. on the Compliance of the Share Issuance Process and Subscribers for Hangzhou High-Tech Materials Technology Co., Ltd.'s Private Placement
    SZSI · 2026/11/13
  • Rating change
    Baird Maintains Tetra Tech Inc(TTEK.US) With Hold Rating, Raises Target Price to $40
    Market Newswire · 2026/11/12
  • Company notice
    Jinhai High-Tech: Legal Opinion of Shanghai Duan & Duan Law Firm on the Third Extraordinary Shareholders' Meeting of Zhejiang Jinhai High-Tech Co., Ltd. for 2026
    SZSI · 2026/11/14
  • Maxim Group Maintains Tetra Tech Inc(TTEK.US) With Hold Rating
    Market Newswire · 2026/11/15
  • Rating change
    Truist Financial Maintains ODDITY Tech(ODD.US) With Hold Rating, Raises Target Price to $20
    Market Newswire · 2026/11/12
  • Rating change
    Argus Research Downgrades Bio-Techne(TECH.US) to Sell Rating
    Market Newswire · 2026/10/27
  • AI Boom Faces Scrutiny Over Returns; Earnings Reports from U.S. Tech Giants Trigger Market Plunge
    Global Market Report · 2026/11/1
  • AI-driven dip-buying strategies fail this time? Tech stocks face severe penalties following earnings misses, while U.S. equity volatility surges.
    Zhitong Finance · 2026/10/31
  • Company notice
    SILTRIUM TECH CORP. | 10-K: Annual report
    SEC · 2026/10/30
  • Elizabeth Warren Slams Trump's Voluntary AI Safety Deal With Tech CEOs, Says Republicans Aren't Doing Enough to Regulate AI: 'Not Lifting A Finger...'
    Benzinga · 2026/10/31

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:25 · For reference only, not investment advice and not tailored to your situation.

Bio-Techne discussion 0 comments

Add a comment